SATO Mitsunobu Last updated: Sep 26, 2007 at 00:00
Name
SATO Mitsunobu Affiliation
Former Institution / Organization The University of Tokushima School of Dentistry Dentistry Degree
Doctor of Philosophy (Dental Medicine)
Academic & Professional Experience
1970
-
1979
Osaka University, Research Assistant
1979
-
1980
Osaka University, Instructor
1980
- The University of Tokushima, Professor
Education
-
1968
Graduate School, Division of Dental Research, Osaka University
-
1964
Faculty of Dentistry, Osaka University
Misc
Involvement of toll-like receptor 4 signaling in interferon-r production and antitumor effect by streptococcal agent OK-432
J.Nat.Cancer Instifute 95(4) 316-326 2003
International Immunopharmacology 3(3) 643-655 2003
Anti-tumor immune response induced by the fractions derived from OK-432,a streptococcal preparation by using a monoclonal antibody TS-2 that neutralizes the interferon-r-inducing activity of OK-432:comparison between the TS-2-binding and TS-2-unbi...
Clin.Diag.Lab.Immunol. 10(2) 286-292 2003
5-Azacytidine Induction of Stable Myoepithelial and Acinar Cells from a Human Salivary Intercalated Duct Cell Clone(共著)
Cancer Research 47(8) 4453-4459 1987
A Family with Hereditary Lack of T4+ Inducer/Helper T Cell Subsets in Peripheral Blood Lymphocytes(共著)
The Journal of Immunology 132(3) 1071-1073 1984
Books etc
Induction of Differentiation and Apoptosis of Cancer Cells ーDifferentiation Therapy of Cancerー
Kyoritsu Shuppan, Ltd 1995
Human Cell Culture Vol. 1 Chapter 9. Salivary gland tumors
Klumer academic publishers 1998
Human Cell Culture Vol.1. Cancer Cell Lines Part 1 Chapter 9. Salivary Gland Tumors
Kluwer Academic Publishers 1999
Works
Isolation and characterization of cytokine-inducing molecule from OK-432 and its action mechanism for host immune function
1999 - 2002
Research Grants & Projects
Differentiation therapy for salivary gland cancer
Funded Research
Project Year: 1968
Differentiation therapy for head and neck squamous cell carcinoma
Funded Research
Project Year: 1968
Study of therapy for herpes simplex virus infection
Funded Research
Project Year: 1968
Immunochemotherapy for Oral Cancer
Funded Research
Project Year: 1975
Toll-like receptor-4 and antineoplastic effect
Patents
Carcinostatic agent AZP23191-P
*
